Indeed, RH10 peptide, comprising only 10 amino acids of GRK5-RH sequence, is able to reduce cancer cells proliferation in vitro and to inhibit tumor growth in vivo in a dose-dependent manner by inhibiting NFκB activity. This evidence concerns the gene NFKB1 and neoplasm.